SCHEMBL329720

SCHEMBL329720

c1cc2cnncc2[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2079963 1.00 AHR (0.44)
SCHEMBL29882403 1.00
SCHEMBL28080236 0.70 PIK3CD (0.37)
SCHEMBL12470 0.70
SCHEMBL706764 0.70 MAPT (0.50)
SCHEMBL30205720 0.70
SCHEMBL29465576 0.70
SCHEMBL709416 0.70 PDE3B (0.50)
SCHEMBL67000 0.70
SCHEMBL17372872 0.69 MAPT (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 418 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO claimed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 CN claimed
CN-109476666-A Substituted pyrrolo [2,3-d ] pyridazin-4-ones and pyrazolo [3,4-d ] pyridazin-4-ones as kinase inhibitors 上海复尚慧创医药研究有限公司 2019-03-15 CN claimed
CN-108367049-A The combination preparation of PKM2 conditioning agents and HMGB1 海德堡吕布莱希特-卡尔斯大学 2018-08-03 CN claimed
CN-1170829-C Optically active pyrrolopyridazine compound ������������ʽ���� 2004-10-13 CN claimed
US-4871653-A DEVELOPING IN PRESENCE OF MERCAPTO POLYAZAINDENE PROMOTERS AND NUCLEATING QUATERNARY OR HYDRAZIDE-TYPE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 1989-10-03 US claimed
WO-2026103730-A1 DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE 江苏恩华药业股份有限公司 2026-05-21 WO disclosed
US-12378255-B2 Toll-like receptor antagonist compounds and methods of use DYNAVAX TECHNOLOGIES CORPORATION (US) 2025-08-05 US disclosed
US-20250144093-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS AGIOS PHARMACEUTICALS, INC. 2025-05-08 US disclosed
WO-2025082069-A1 COMPOUND BINDING TO CRBN PROTEIN AND DEGRADATION AGENT OF PROTEIN 中国海洋大学 2025-04-24 WO disclosed
CN-119841843-A Compound combined with CRBN protein and degradation agent of CRBN protein 中国海洋大学 2025-04-18 CN disclosed
US-12215105-B2 HPK1 antagonists and uses thereof Nimbus Saturn, Inc. (US) 2025-02-04 US disclosed
US-12133853-B2 Pyruvate kinase activators for use in treating blood disorders AGIOS PHARMACEUTICALS, INC. (US) 2024-11-05 US disclosed
CN-1370172-A Optically active pyrrolopyridazine compound SANKYO CO (JP) 2002-09-18 CN disclosed
CN-1284078-A Heterocyclic compounds for inhibiting gastric acid secretion, process for their preparation and pharmaceutical compositions containing them ASTRA ZENECA LTD (SE) 2001-02-14 CN disclosed
EP-1042324-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF AstraZeneca AB (SE) 2000-10-11 EP disclosed
CN-1044811-C Pyrrolopyridazine derivatives SANKYO CO (JP) 1999-08-25 CN disclosed
WO-1999028322-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF ASTRAZENECA AB (SE) 1999-06-10 WO disclosed
CN-1143964-A Pyrrolopyridazine derivative SANKYO CO (JP) 1997-02-26 CN disclosed
US-4871653-A DEVELOPING IN PRESENCE OF MERCAPTO POLYAZAINDENE PROMOTERS AND NUCLEATING QUATERNARY OR HYDRAZIDE-TYPE COMPOUNDS FUJI PHOTO FILM CO., LTD. (JP) 1989-10-03 US disclosed